Cosentyx sensoready 150 MG penml
Ended Awarded Last action
- Contract number
- SPE2DR26F8E9D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,405
Award facts
- Contract value 100% obligated
- $11,404.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,404.94 to AmerisourceBergen Drug Corp for the supply of Cosentyx SensoReady 150 mg pen/ml, a pharmaceutical product used in treating inflammatory conditions. This competitive, non-set-aside delivery order was executed on February 3, 2026, with an ultimate completion date of February 4, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., functions as a critical pharmaceutical distributor and healthcare solutions provider within the federal medical procurement system, particularly supporting Defense Health Agency and military treatment facilities. The company's federal contract portfolio demonstrates extensive experience delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains through firm fixed-price delivery orders. This specific award exemplifies the company's role in fulfilling essential medication supply requirements for federal military healthcare systems through the DLA's pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26F8E9D?
SPE2DR26F8E9D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 3, 2026.
How much is contract SPE2DR26F8E9D worth?
The government has obligated $11,405 on SPE2DR26F8E9D.
Is contract SPE2DR26F8E9D an order under another contract?
Yes. SPE2DR26F8E9D is a delivery order under SPE2DR25D3202, an indefinite delivery contract.
Was contract SPE2DR26F8E9D competed?
The extent of competition for SPE2DR26F8E9D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award